MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2018 International Congress

    An open labeled, observational study for the Satisfaction and Preference of the Rivastigmine patch for treatment of Alzheimer’s disease and Parkinson’s disease dementia (SAFE-ADPD) in Koreans

    M. Park, D. Shin (Daegu, Republic of Korea)

    Objective: This study performed to access caregiver’s satisfaction and preference of the Rivastigmine patch for treatment of Alzheimer’s disease and Parkinson’s disease dementia patients to…
  • 2018 International Congress

    Using Vision to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: To identify visual measures that relate to higher risk of dementia in Parkinson’s Disease (PD). Background: Dementia affects 50% of people with PD within…
  • 2017 International Congress

    Familial Creutzfeldt-Jakob Disease with an E200K Mutation in Peru: A Case Report

    H. Sarapura-Castro, C. Cosentino, L. Torres-Ramirez, P. Parchi, A. Vishnevetsky, M. Inca-Martinez, E. Figueroa-Ildefonso, P. Mazzetti, M. Cornejo-Olivas (Lima, Peru)

    Objective: To describe the clinical and molecular features of a familial Creutzfeldt-Jakob Disease (fCJD) case in Peru.  Background: Creutzfeldt - Jakob disease (CJD) is characterized…
  • 2017 International Congress

    Do Acetylcholinesterase Inhibitors (AChEI) delay institutionalisation in Parkinson’s and Lewy Body Disease?

    L. Brown, B. Mohamed, E. Thomas (Cardiff, United Kingdom)

    Objective: We explored the use of Rivastigmine in Parkinson’s and Lewy body dementia through assessment of quantitative data obtained from a clinical database. We focussed…
  • 2017 International Congress

    Late-Onset Wilson’s disease, Dementia, Ekbom syndrome and whitte matter hyperintensities

    F. Germiniani, P. Marques, F. Zorzetto, L. de Oliveira, H. Teive (Curitiba, Brazil)

    Objective: The aim of this study is to describe a patient with late-onset Wilson’s disease, dementia and Ekbom Syndrome. Background: Wilson's disease is an autosomal-recessive disorder…
  • 2017 International Congress

    Apolipoprotein E ε4 allele frequency in Korean Patients with Parkinson’s disease Dementia

    M. Park (Daegu, Republic of Korea)

    Objective: The Apo E allele frequencies were evaluated in Korean patients with probable PDD diagnosed by the MDS task force criteria for the diagnosis of…
  • 2017 International Congress

    Analysis of related factors of occurrence of dementia in Parkinson’s disease using the application form of Parkinson’s disease provided by the specific diseases treatment research program of Ministry of Health, Labor and Welfare of Japan

    K. Konaka, M. Mihara, H. Mochizuki (Suita, Japan)

    Objective: Dementia has now been noticed as a significant non-motor symptom of Parkinson's disease (PD). We attempted to analyze the relation between the occurrence of…
  • 2017 International Congress

    An unusual case of sporadic Creutzfeld Jacob disease presenting as acute neuropathy

    R. Hanumanthu, A. Alchaki, A. Nyaboga, H. Ghuman, J. Chen, E. Feinstein (Newark, NJ, USA)

    Objective: To describe an unusual case of sporadic Creutzfeld Jacob Disease (CJD) that initially presented with ascending tingling of lower extremities. Background: Prion diseases are…
  • 2017 International Congress

    White matter microstructural damage as predictor of cognitive decline in Parkinson’s disease

    T. Stojkovic, E. Stefanova, F. Agosta, S. Galantucci, I. Stankovic, V. Markovic, E. Canu, M. Copetti, M. Filippi, V. Kostic (Belgrade, Serbia)

    Objective: To investigate patterns of cortical and white matter (WM) changes associated with progression to mild cognitive impairment (MCI) or dementia in patients with Parkinson’s…
  • 2017 International Congress

    Clinical Predictors of Dementia and Other Non-Motor Symptoms in Parkinson’s Disease

    D. Lichter, S. Finnegan (Buffalo, NY, USA)

    Objective: To clarify clinical predictors (pX) of dementia and other non-motor symptoms (NMS) in Parkinson's disease (PD). Background: The postural instability-gait disorder (PIGD) phenotype has…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley